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Abstract
Incidence of whooping cough, an infection caused by Bordetella pertussis and Bordetella
parapertussis, has been on the rise since the 1980s in many countries. Immunologi-
cal interactions, such as immune boosting and cross-immunity between pathogens, have
been hypothesised to be important drivers of epidemiological dynamics. We present a
two-pathogen model of transmission which examines how immune boosting and cross-
immunity can influence the timing and severity of epidemics. We use a combination of
numerical simulations and bifurcation techniques to study the dynamical properties of
the system, particularly the conditions under which stable periodic solutions are present.
We derive analytic expressions for the steady state of the single-pathogen model, and give
a condition for the presence of periodic solutions. A key result from our two-pathogen
model is that, while studies have shown that immune boosting at relatively strong levels
can independently generate periodic solutions, cross-immunity allows for the presence
of periodic solutions even when the level of immune boosting is weak. Asymmetric
cross-immunity can produce striking increases in the incidence and period. Our study
underscores the importance of developing a better understanding of the immunologi-
cal interactions between pathogens in order to improve model-based interpretations of
epidemiological data.
Keywords: infectious disease modelling, bifurcation, multi-pathogen dynamics,
pertussis
1. Introduction
Understanding immune-mediated interactions of closely related pathogens, such as
cross-immunity, can be important in explaining the epidemiological patterns of infectious
diseases (Adams et al., 2006; Bhattacharyya et al., 2015). Multi-pathogen models with
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cross-immunity (Restif and Grenfell, 2006; Restif et al., 2008; Zhang et al., 2004) are
based on extensions of the susceptible-infectious-recovered-susceptible (SIRS) model of
infectious disease transmission (Keeling and Rohani, 2008), where each individual in a
homogeneously mixing population is categorised into one of three classes: susceptible
(S) to infection; infectious (I) if they can transmit the infection; or recovered (R) if they
have cleared the infection and are (temporarily) immune. As immunity wanes over time,
those who are recovered become susceptible once again.
While the mechanisms through which cross-immunity affects infection remain unclear,
it is commonly assumed in mathematical models that cross-immunity acts by reducing
susceptibility (Kamo and Sasaki, 2002; Restif and Grenfell, 2006; Restif et al., 2008),
reducing infectivity (White et al., 1998), or by polarised immunity (Gog and Swinton,
2002; Gog and Grenfell, 2002) in which individuals are either fully susceptible or fully
immune immediately following infection. The equilibrium dynamics of multi-pathogen
SIR-type models with cross-immunity have been studied to find conditions for coexistence
(Nun˜o et al., 2005; Vasco et al., 2007; White et al., 1998), the presence of sustained
oscillations (Andreasen et al., 1997; Nun˜o et al., 2005) or the lack thereof (Castillo-
Chavez et al., 1989; Gog and Swinton, 2002).
In a study of seroepidemiology of Bordetella pertussis infections, Cattaneo et al. (1996)
hypothesised that the maintenance of high antibody levels for pertussis components in the
absence of typical pertussis symptoms may be due to immune boosting. This immuno-
logical interaction coincides with a subsequent increase (boosting) of immunity levels in
individuals following re-exposure, and has been captured in mathematical models of per-
tussis (A´guas et al., 2006; Dafilis et al., 2012, 2014a,b; Lavine et al., 2011). Contrary to
A´guas et al. (2006) who interpreted immune boosting as an estimate of vaccine efficacy,
Lavine et al. (2011) parameterised it as the amount of antigen exposure required to stim-
ulate a boost in immunity relative to the amount required to produce an infection in a
fully susceptible (immunologically naive) individual. Furthermore, Lavine and colleagues
hypothesised that the amount of antigen required to trigger a boost in immunity may
be less than that required to produce a naive infection, implying that “boosts” may be
more easily triggered than naive infections. With age structure and vaccination added
to Lavine’s susceptible-infectious-recovered-waning-susceptible (SIRWS) model, Lavine
et al. (2011) reproduced the patterns of pertussis incidence data from Massachusetts,
USA. Subsequently, Dafilis et al. (2012) demonstrated that the SIRWS model without
vaccination and age structure is capable of generating damped and undamped oscilla-
tions, and chaos in the presence of seasonally forced transmission (Dafilis et al., 2014a,b).
Pertussis notifications have been rising since the 1980s (Cherry, 2003), and studies have
found that infections caused by Bordetella parapertussis—a bacteria capable of causing
symptoms similar to a B. pertussis infection—are not uncommon (Bokhari et al., 2011;
Cherry and Seaton, 2012; He et al., 1998). The two Bordetella pathogens are closely re-
lated, and studies using a murine model of infection have considered the level of protection
gained from infection-induced immunity of one Bordetella pathogen against subsequent
infections with the other (Watanabe and Nagai, 2001; Wolfe et al., 2007; Worthington
et al., 2011). The results from these studies are inconclusive, but suggest existence of
cross-immunity and perhaps asymmetry in this interaction. The two pathogens have
been observed to exhibit strikingly out of phase recurrent epidemics (Lautrop, 1971)—
behaviour that may plausibly be induced by cross-immunity.
Our study investigates the immune-mediated interactions between two pathogens and
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considers how they may manifest in infectious disease epidemiology. While the applica-
tion for this model is motivated by whooping cough, the same methods may be adapted
to describe other multi-pathogen diseases, such as influenza (Mathews et al., 2009). In
Section 2, we introduce a two-pathogen extension of the SIRWS model that incorpo-
rates immune boosting and cross-immunity. In Section 3, we carry out the analysis to
find periodic solutions in the system. The results in Section 4 illustrate how periodic
solutions can be generated under a range of scenarios for the degree of cross-immunity
and strength of immune boosting. Section 5 summarises our findings and discusses their
epidemiological relevance.
2. The SIRWS model with cross-immunity and immune boosting
The SIRWS model (Lavine et al., 2011) extends the SIRS model by further dividing the
population of immune individuals into two classes based on their level of immunity. Those
in the recovered (R) class are fully immune. Those whose immunity has waned sufficiently
(W) may either lose their immunity and return to the susceptible class, or have their
immunity boosted upon re-exposure and return to the recovered class. The system is
mathematically represented by the following set of ordinary differential equations (ODEs)
for the proportions of the population in each class:
dS
dt
= µ(1− S)− βIS + 2κW , (1a)
dI
dt
= βIS − γI − µI , (1b)
dR
dt
= γI − 2κR+ νβIW − µR , (1c)
dW
dt
= 2κR− 2κW − νβIW − µW , (1d)
where β is the transmission rate, and γ the recovery rate. Births and deaths occur at
equal rates µ, so that the population size remains fixed. Disease-induced mortality is not
considered. Immunity is lost at a rate κ. The transition time from R to S in the absence
of boosting is 2/(2κ + µ), so that for µ  κ, the average total duration of immunity
is approximately 1/κ. Immune boosting occurs at a rate νβI proportional to the force
of infection βI, where ν is the relative strength of immune boosting (ν ≥ 0). Allowing
ν > 1 implies that immune boosting may be more easily triggered than a naive infection.
The addition of the immune boosting term produces limit cycles (Dafilis et al., 2012)—
dynamics that are qualitatively different to those of the SIRS model, a system known
never to exhibit limit cycles.
Our model builds on the SIRWS framework and includes the cross-protective inter-
actions of a second pathogen. The model is described by a system of sixteen ODEs in
Appendix A and will henceforth be referred to as the two-pathogen model. A descrip-
tion of the parameters is provided in Table 1. As depicted by a flow diagram in Figure
1, the population is divided into classes labelled Xmn, where m and n represent indi-
viduals with that class’s disease status with respect to the first and second pathogen,
for m,n ∈ {S, I,R,W}. Infection with one pathogen confers cross-immunity against
infection with the other pathogen. Those who are infectious, recovered, or waning with
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XSS XIS XRS XWS
XSI XII XRI XWI
XSR XIR XRR XWR
XSW XIW XRW XWW
µ λ1 γ1 2κ1
ν1λ1
(1− σ1)λ1 γ1 2κ1
ν1λ1
(1− σ1)λ1 γ1 2κ1
ν1λ1
(1− σ1)λ1 γ1 2κ1
ν1λ1
(1− σ2)λ2
γ2
2κ2 ν2λ2
(1− σ2)λ2
γ2
2κ2 ν2λ2
(1− σ2)λ2
γ2
2κ2 ν2λ2
(1− σ2)λ2
γ2
2κ2 ν2λ2
Figure 1: A flow diagram of the two-pathogen SIRWS model. Boxes represent the compartments into
which the population partitions, and arrows represent the rates at which individuals transfer between
compartments. The force of infection λi is the transmission coefficient times the sum of those infectious
with pathogen i = 1, 2. For brevity, the dashed ( ) and dotted ( ) arrows represent the immunity
waning rates 2κ1 and 2κ2, respectively. The death rate µ is represented by a bullet ( ).
respect to pathogen j gain a proportional reduction in the force of infection for pathogen
i by a factor (1 − σi), for (i, j) = (1, 2), (2, 1). A value of σ = 0 represents no cross-
immunity. As σ approaches one, full cross-immunity is attained. Throughout the paper,
we assume that cross-immunity is conferred upon infection, as opposed to recovery, and
acts by reducing an individual’s susceptibility to the second pathogen. However, cross-
immunity may act through other ways, such as a reduction in infectivity, which may be
adapted to the two-pathogen model (described in Appendix A).
3. Methods
To identify periodic solutions in the single-pathogen SIRWS model described by Equa-
tions (1), we used Latin hypercube sampling (LHS) (Blower and Dowlatabadi, 1994) to
simultaneously sample through all parameters from a uniform distribution using MAT-
LAB (2014). The range of each parameter was divided into 100 equiprobable intervals.
Parameter ranges, taken from a study of pertussis by Campbell et al. (2015), were set
to an average life expectancy 1/µ between 50 to 100 years; the average duration of in-
fectiousness 1/γ between 7 to 35 days; the average duration of immunity 1/κ between
1 to 100 years; and the relative strength of immune boosting ν between 0 and 5. Due
to limited quantitative data on immune boosting, we allow immune boosting to be in-
hibited (ν < 1) or enhanced (ν > 1) during re-exposure to the pathogen. However,
we particularly focus on the system dynamics when the strength of immune boosting is
4
Parameter Description Default LHS Range
U(a, b)
µ Birth and death rate 1/80 y−1 (0.01, 0.02)
γi Recovery rate of infection with pathogen i 17 y
−1 (10.4, 52)
κi Loss of immunity rate for infection with pathogen i 1/10 y
−1 (0.01, 1)
νi Immune boosting strength for infection with pathogen i 1 (0, 5)
βi Rate of transmission 260 p
−1y−1 (200, 350)
σi Protection conferred by infection with pathogen j against
pathogen i
[0, 1]
Table 1: Table of parameters and their meanings for the two-pathogen SIRWS model. All Latin hyper-
cube sampling parameter ranges except β were taken from Campbell et al. (2015). (i = (1, 2), y = years;
p = person)
relatively weak (ν ≤ 1), as the dose of antigens required to stimulate an immune boost
is unclear and warrants further examination. We chose the transmission coefficient β
to range between 200 to 350, encompassing a basic reproductive ratio R0 = β/(γ + µ)
between 5.7 to 31.8.
We generated 20,000 parameter sets using LHS. Each parameter set comprised one en-
demic equilibrium. The procedure used to determine the presence of periodic solutions
for each equilibrium follows. We derived analytic expressions for the endemic equilibrium
of the SIRWS model. By evaluating the Jacobian of the SIRWS model at the endemic
equilibrium, the characteristic equation can be determined. It follows that if the Routh–
Hurwitz criteria (Gantmacher, 1959) were satisfied, all eigenvalues have negative real
parts, and the endemic equilibrium is locally asymptotically stable. Otherwise, it is un-
stable. For analytic expressions of the endemic equilibrium and details on the procedure
used to determine stability, the reader is referred to Appendix B.
The equations of the two-pathogen model were solved using the numerical soft-
ware XPPAUT (Ermentrout, 2002) with an adaptive step size Runge–Kutta integrator
(Qualst.RK4). Unless specified otherwise, the default model parameters for simulations
are detailed in Table 1, similar to the ones used by Lavine et al. (2011) in their study
of pertussis. The initial conditions were XSS = 0.99, XIS = XSI = 0.005, and all other
states were set to 0. To focus on the effect of cross-immunity, throughout this paper,
we impose the two pathogens to be characteristically indistinguishable (β1 = β2 = β,
γ1 = γ2 = γ, κ1 = κ2 = κ, ν1 = ν2 = ν).
As the two-pathogen model is high-dimensional, our analysis is primarily numerical.
Bifurcation analysis was done in XPPAUT with the first 400 years of integration time
discarded as a transient with post-processing in MATLAB (2014). To illustrate different
qualitative behaviours in the bifurcation diagrams, we display the variable XIS .
4. Results
4.1. Absence of sustained oscillations in the single-pathogen SIRWS model for ν ≤ 1
Previously, Dafilis et al. (2012) showed that the SIRWS model described by Equations
(1) may exhibit limit cycles for a subset of the parameter space as the birth rate and
strength of boosting change simultaneously. Here we expand on this work and vary all
parameters simultaneously to determine the presence of periodic solutions throughout
the entire parameter space.
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Figure 2: Numerical calculations run with 20,000 LHS-sampled parameter sets. For each parameter set,
the Routh–Hurwitz criterion was employed. A gray dot represents the case when all characteristic roots
were found to have negative real parts, and a black dot otherwise. The dashed (- - -) line represents
ν = 1.
The values of each LHS-generated parameter set are displayed as dots in Figure 2.
The colour of the dot represents the stability of the equilibrium consisting of the pa-
rameter set: gray when locally asymptotically stable, and black when unstable. We find
through numerical calculations that the endemic equilibrium loses stability through a
Hopf bifurcation to give rise to sustained oscillations (explored in detail in Section 4.2).
Interestingly, sustained oscillations are observed only when ν > 1, independent of the
other parameter values. Thus, the equations of the SIRWS system may only produce
periodic solutions when immune boosting is more easily triggered than a naive infection
(νβI > βI). However, if ν ≤ 1, the dynamics of the model are always characterised
by a point attractor reached via damped oscillations, thus failing to capture the cyclic
dynamics of some infectious diseases, such as pertussis (Lautrop, 1971).
4.2. Cross-immunity allows for sustained oscillations for ν ≤ 1
In the absence of cross-immunity (σ1 = σ2 = 0) and with symmetric initial conditions,
Xmn = Xnm for all time. By using the following substitutions:
XS• = XSS +XSI +XSR +XSW ,
XI• = XIS +XII +XIR +XIW ,
XR• = XRS +XRI +XRR +XRW ,
XW• = XWS +XWI +XWR +XWW ,
the two-pathogen model collapses to the single-pathogen SIRWS model; hence, the pres-
ence of periodic solutions for this special case is described in Section 4.1.
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Figure 3: (Colour online) One-parameter bifurcation diagrams of XIS as a function of σ1 = σ2 = σ
for (a) ν = 0, (b) ν = 0.2, (c) ν = 0.5, (d) ν = 1, (e) ν = 3, (f) ν = 10, and (g) ν = 15. The fixed
point is represented by a line: stable (solid) or unstable (dashed). Blue dots indicate stable periodic
solutions, and open circles show when periodic solutions are unstable. Red open circles represent a Hopf
bifurcation, and a red cross in (e) and (f) represents a torus bifurcation. The loci of Hopf bifurcation
points are displayed in (h). Five regions, separated by red lines, are labelled to guide discussion in the
main text. (µ = 1/80, γ = 17, κ = 0.1, β = 260, hence R0 ≈ 15.)
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We now consider the presence of symmetric cross-immunity (σ1 = σ2 = σ > 0). Figure
3(a)–(g) present one-dimensional bifurcation diagrams of XIS as a function of σ for seven
different values of the boosting parameter ν. In (h), when σ and ν are co-varied, lines of
Hopf points describe regions in the parameter space with different dynamical behaviours.
The shaded areas indicate where periodic solutions occur. Five regions are labelled based
on different qualitative behaviours arising from the Hopf bifurcations:
1. 0 ≤ ν < 2.06
2. 2.06 ≤ ν < 4.13
3. 4.13 ≤ ν < 13.62
4. 13.62 ≤ ν < 15.64
5. ν ≥ 15.64.
The values of ν in Figure 3(d)–(g) were chosen to each represent a plane in regions 1
to 4. Collectively, Figure 3 displays how the family of periodic solutions appearing at
ν = 0.2 (b) transforms as ν increases, and eventually disappears in region 5.
Region 1 (0 ≤ ν < 2.06) is of particular interest as its parameter space can be di-
chotomised into regions where immune boosting is inhibited (ν < 1) or enhanced (ν > 1)
relative to the force of infection. In the limiting case ν = 0, the fixed point undergoes no
bifurcation and remains stable (Figure 3(a)). In contrast, as ν increases to 0.2 (b), the
system undergoes a Hopf bifurcation (σ ≈ 0.9), giving rise to sustained oscillations with
amplitudes increasing with σ. The amplitude drops sharply as the system approaches the
second Hopf bifurcation (σ ≈ 0.96). As expected, periodic solutions are enclosed within
the two Hopf points. When ν increases further to 0.5 (c), the amplitude as a function
of σ appears nonlinear as there is a gradual dip between the two Hopf points. At ν = 1
(d), the nonlinear relationship between the amplitude and σ is even more noticeable.
There is a rapid decrease in amplitude followed by a steep increase between the two Hopf
points. Additionally, the family of periodic solutions extends past the second Hopf point
which gives rise to a region of bistability (inset, (d)). Which attractor the system settles
to over time in the bi-stable region is determined by initial conditions, as exemplified in
Appendix C.
4.3. Sustained oscillations for ν > 1 and their dynamical properties
Figure 3(e) reveals branches of periodic solutions that can assume complicated shapes,
showing an interesting and nontrivial sequence of stable and unstable families of oscil-
lations. At σ = 0, there is no interaction between the two pathogens, and the system’s
behaviour is described by the one-pathogen model. As Dafilis et al. (2012) have shown,
at ν = 3, the system has stable periodic solutions. We find that these periodic solutions
remain stable for small values of σ, losing stability at σ ≈ 0.14 and extending to σ ≈ 0.33.
At σ = 1, which models full cross-immunity between pathogens, there is a stable fixed
point, which loses stability at σ ≈ 0.98, giving rise to stable periodic solutions down to
σ ≈ 0.65. (Note, there is a narrow bi-stable region for large σ.) This family of periodic
solutions, having lost stability, extends to σ = 0.
In addition to the two families of periodic solutions, Figure 3(f) at ν = 10 features a
third family of periodic solutions that extends to σ = 1. Interestingly, two families of
oscillations are seen overlapping in parameter space (inset, (f)), suggesting that multi-
stability of different periodic solutions may be present. The variability in the amplitude
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Figure 4: Time series of the two-pathogen model when ν = 1 and (a) σ = 0.7, (b) σ = 0.8, and (c)
σ = 0.9. XI• is shown by a solid line, and XIS in dashed line.
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Figure 5: Diagrams of the period for regions 1, 2, 3, and 4 at (a) ν = 1, (b) ν = 3, (c) ν = 10, and (d)
ν = 15, respectively.
of oscillations in the limited interval for high σ values is also observed for lower values of
ν. At an even higher ν value of 15 (g), the periodic branch connecting the two Hopf points
appears more regular, in the sense that the amplitude of the stable locus monotonically
decreases to the second Hopf point with increasing σ. It is interesting to note that the
steep increase in amplitude following the rapid decrease, as observed in (d)–(f), is absent
in (g).
In the epidemiological context, the presence of overlapping attractors—each with dif-
ferent amplitudes as observed in the inset of Figure 3(f)—may have considerable impact.
Consider a scenario where a small perturbation, perhaps as a result of stochastic effects,
shifts the population to a different regime. This could translate to an increased health
burden. Further, sudden drops—or conversely, spikes—in incidence, as a result of shifts
between different attractors or the high variability in amplitude for high values of σ,
would be anticipated to make prediction of disease burden difficult.
A relatively small change in σ can produce strikingly different periodic behaviours
in terms of period, amplitude, and wave shape (Figure 4). The peaks of XI•, those
infectious with the first pathogen, is reduced by half as σ changes from 0.7 to 0.8, and
the interepidemic interval is longer, as illustrated in Figure 4(a)–(b). Comparing (b) to
(c), as σ increases further to 0.9, the interepidemic interval continues to grow, and the
peaks of XIS are higher. The number of peaks in a full cycle also changes from one to
two.
The period of the cycles generally increases with σ (Figure 5), with the rate of increase
steeper for higher values of σ. Noticeably, the steep increase is missing for ν = 15 (d).
Its period appears consistent with the periods of (a)–(c) for lower values of σ.
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Figure 6: Scenarios with different σ and initial conditions: XSS = 0.058, XIS = XSI = 0.001, XWS =
XSW = 0.1, and unspecified states set to 0 (ν = 2). The upper row has (XRS , XSR) = (0.41, 0.33), and
(a) σ = 0.49, (b) σ = 0.50, and (c) σ = 0.51. The lower row has (XRS , XSR) = (0.405, 0.335) and (d)
σ = 0.49, (e) σ = 0.50, and (f) σ = 0.51.
4.4. Dependence on initial conditions
Symmetric initial conditions lead the two pathogens to coexist with the same incidence,
period, and amplitude either endemically or while oscillating in phase. However, a small
deviation from the symmetric initial conditions can lead to antiphase oscillations with
different incidence peaks and amplitudes for the two pathogens—a dramatic change in
the dynamical behaviour of the system.
An example is shown in Figure 6, where simulations from the top row, (a)–(c), are run
with the same set of initial conditions, and the bottom row (d)–(f) with a different set.
In a similar fashion, simulations paired by each column ((a) and (d); (b) and (e); and (c)
and (f)) are run with the same value of σ. The oscillations with smaller amplitude also
coincide with a lower incidence peak. Small changes in initial conditions (comparing (b)
and (e)) or changes in parameterisation (comparing (a) and (b)) can result in different
dominant pathogens. The former suggests that multi-stability may be present.
This may manifest in an epidemiological context when considering a vaccination cam-
paign, in which susceptibles are impulsively shifted to resistant classes. Subtle differences
in proportions of the population that are shifted may lead to dramatic changes in the
dominance of one pathogen over another.
4.5. Dynamical behaviour when cross-immunity is not symmetric
Here we briefly study the effect of two antigenically distinct pathogens. We model
asymmetry in cross-immunity by allowing σ1 and σ2 to differ. We write σ2−σ1 = , noting
that  = 0 corresponds to the earlier sections where the two pathogens are antigenically
indistinguishable. We start by enforcing σ1 = 0.42, a value in the neighbourhood of
the Hopf point (σH = 0.428; Figure 3(d)) when cross-immunity is symmetric. We set
σ2 = σ1 + , for  ∈ {0.01, 0.02, 0.03}. As  grows, the two pathogens can exhibit
antiphase oscillations with different amplitudes, as illustrated in Figure 7(a)–(c). In our
example, the pathogen conferring more cross-immunity (the second pathogen) oscillates
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Figure 7: (Colour online) Time series of the two-pathogen model with asymmetric cross-immunity when
ν = 1, σ1 = 0.42, and σ2 = σ1 + . XIS (solid) and XSI (dashed) are plotted for (a)  = 0 (red) and
0.01 (black), (b)  = 0.02 (blue), and (c)  = 0.03 (orange). For varying σ1, the corresponding periods
of the sustained oscillations for XIS are shown in (d), represented in the same colours.
at higher amplitude. The difference in amplitudes increases with . This indicates that in
addition to changes in initial conditions as discussed in Section 4.4, antigenic asymmetry
may play a role in determining the dominant pathogen. Furthermore, note that both
pathogens display oscillatory behaviour even though σ1 < σH , indicating that asymmetry
can change the conditions under which a pathogen can sustain oscillations.
Allowing σ1 to vary, the periods of oscillations for each value of  are shown in Figure
7(d) as a function of σ1. For intermediate values of σ1, different values of  produce
negligible differences in the periods of oscillations, as shown by the nearly overlapping
lines for 0.4 . σ1 . 0.8. However, for large values of σ1, a small change in  can result
in a considerable difference in period, as observed in the inset. Moreover, two distinct
values of σ1 can sustain the same period. For example, when  = 0.03 (orange curve), a
period of 12 years can be sustained at σ1 ≈ 0.927 and σ1 ≈ 0.952.
5. Discussion
We have demonstrated that a two-pathogen model of disease transmission with immune
boosting and cross-immunity can produce behaviours that are qualitatively similar to the
incidence patterns of B. pertussis and B. parapertussis as observed by Lautrop (1971),
including antiphase oscillatory dynamics. Our analysis shows that cross-immunity can
induce sustained oscillations when immune boosting is both enhanced (ν > 1) or inhibited
(ν < 1) by re-exposure. In contrast, sustained oscillations were generated in the single-
pathogen SIRWS system only when immune boosting was enhanced, i.e., ν > 1 (See
Figure 2, Dafilis et al. (2012), and Lavine et al. (2011)). Our study finds that the level
of reduced susceptibility (σ) has a significant effect on the shape, amplitude, and period
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of oscillations. Interestingly, initial conditions can determine which one out of the two
characteristically and antigenically similar pathogens is dominant.
Our study underscores the importance of developing a better understanding of im-
munological interactions between pathogens to better inform model-based interpreta-
tions of epidemiological data. We have shown that the degree of cross-immunity and
strength of immune boosting may determine the epidemiological behaviour of a disease
with both endemic and cyclic (oscillatory) dynamics supported. Under weak levels of
immune boosting, a high degree of cross-immunity may introduce a cyclic regime (Figure
3). In contrast, as the rate of immune boosting grows to be equal to the force of infec-
tion, only intermediate levels of cross-immunity may be required for cyclic behaviour.
Determining the likely strength of immune boosting would provide guidance on its role
in the maintenance of immunity.
We have not investigated in detail the basins of attraction for the different dynamical
regimes identified in our study. Bifurcation analysis of the two-pathogen model performed
here indicates that multi-stability is present. The complicated shapes of the Hopf bifur-
cation branches suggest that the structure of the basins of attraction may be similarly
intricate. Their structure may inform the system’s sensitivity to initial conditions.
The mechanisms behind immunity are not well understood. Different types of immu-
nity, such as natural and vaccine-induced, act together to maintain population immunity,
which is further complicated by immune boosting. Incorporation of vaccination in future
work may untangle effects arising from the interplay between natural and vaccine-induced
immunity. As multiple factors are capable of generating sustained oscillations in dynamic
transmission models, how much immune boosting, cross-immunity, and vaccination con-
tribute to the overall observed recurrence of epidemics of infectious diseases remains an
open question.
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Appendix A. The two-pathogen model
In this appendix, the equations for the two-pathogen SIRWS model are given. The
equations track the immune history of each class in a population, given by
dXSS
dt
= µ+ 2κ1XWS + 2κ2XSW − (λ1 + λ2 + µ)XSS , (A.1a)
dXIS
dt
= λ1XSS + 2κ2XIW − ((1− σ2)λ2 + γ1 + µ)XIS , (A.1b)
dXRS
dt
= γ1XIS + 2κ2XRW + ν1λ1XWS − ((1− σ2)λ2 + 2κ1 + µ)XRS , (A.1c)
dXWS
dt
= 2κ1XRS + 2κ2XWW − ((1− σ2)λ2 + ν1λ1 + 2κ1 + µ)XWS , (A.1d)
dXSI
dt
= λ2XSS + 2κ1XWI − ((1− σ1)λ1 + γ2 + µ)XSI , (A.1e)
dXII
dt
= (1− σ1)λ1XSI + (1− σ2)λ2XIS − (γ1 + γ2 + µ)XII , (A.1f)
dXRI
dt
= γ1XII + (1− σ2)λ2XRS + ν1λ1XWI − (2κ1 + γ2 + µ)XRI , (A.1g)
dXWI
dt
= 2κ1XRI + (1− σ2)λ2XWS − (νλ1 + 2κ1 + γ2 + µ)XWI , (A.1h)
dXSR
dt
= γ2XSI + 2κ1XWR + ν2λ2XSW − ((1− σ1)λ1 + 2κ2 + µ)XSR , (A.1i)
dXIR
dt
= γ2XII + (1− σ1)λ1XSR + ν2λ2XIW − (2κ2 + γ1 + µ)XIR , (A.1j)
dXRR
dt
= γ1XIR + γ2XRI + ν1λ1XWR + ν2λ2XRW − (2κ1 + 2κ2 + µ)XRR , (A.1k)
dXWR
dt
= γ2XWI + 2κ1XRR + ν2λ2XWW − (ν1λ1 + 2κ1 + 2κ2 + µ)XWR , (A.1l)
dXSW
dt
= 2κ1XWW + 2κ2XSR − ((1− σ1)λ1 + ν2λ2 + 2κ2 + µ)XSW , (A.1m)
dXIW
dt
= 2κ2XIR + (1− σ1)λ1XSW − (2κ2 + ν2λ2 + γ1 + µ)XIW , (A.1n)
dXRW
dt
= γ1XIW + 2κ2XRR + ν1λ1XWW − (ν2λ2 + 2κ1 + 2κ2 + µ)XRW , (A.1o)
dXWW
dt
= 2κ1XRW + 2κ2XWR − (ν1λ1 + ν2λ2 + 2κ1 + 2κ2 + µ)XWW , (A.1p)
where
λ1 = β1(XIS + (1− α1)(XII +XIR +XIW )) , (A.2a)
λ2 = β2(XSI + (1− α2)(XII +XRI +XWI)) . (A.2b)
To incorporate cross-immunity through a reduction in infectivity, or the ability to trans-
mit the infection, the force of infection λi becomes the transmission rate times a weighted
sum of those infectious with pathogen i = 1, 2. Those who have experience with infec-
tion with pathogen j become (1−αi) times less infectious than those with no experience,
0 ≤ αi ≤ 1. Throughout the paper, we impose α1 = α2 = 0 (no reduced infectivity).
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Appendix B. Equilibrium of the SIRWS model
In this section, we present the endemic equilibrium of the SIRWS model and determine
its stability using the Routh–Hurwitz criteria (Gantmacher, 1959). Expressions of the
endemic equilibrium for the SIRWS model are given by
S∗ =
γ + µ
β
, (B.1a)
I∗ =
√
c20 + c1ν + c
2
2ν
2 − [4κ2 + (4κ+ µ)(γ + µ)− µν(β − γ − µ)]
2β(γ + µ)ν
, (B.1b)
R∗ =
(2κ+ µ)(γ + µ) + 2κγ
4κ(γ + µ)
(β − γ − µ) + γ + µ+ 2κ
4κβ(γ + µ)ν
c0
(
1−
√
1 + c1ν + c2ν2
)
,
(B.1c)
W ∗ =
√
c20 + c1ν + c
2
2ν
2 − [4κ2 + (4κ+ µ)(γ + µ) + µν(β − γ − µ)]
4κβν
, (B.1d)
where
c0 = (2κ+ µ)
2 + γ(4κ+ µ) ,
c1 =
2(β − γ − µ)[µ(2κ+ µ)2 + γ(8κ2 + 4κµ+ µ2)]
[(2κ+ µ)2 + γ(4κ+ µ)]2
,
c2 =
[µ(−β + γ + µ)]2
[(2κ+ µ)2 + γ(4κ+ µ)]2
.
The Jacobian of the SIRWS system is
J =

−(µ+ βI) −βS 0 2κ
βI −(γ + µ− βS) 0 0
0 γ + βνW −(2κ+ µ) βνI
0 −βνW 2κ −(2κ+ µ+ βνI)
 .
By evaluating J at the endemic equilibrium, the corresponding characteristic equation is
given by
det(J− ΛI) = 0 ,
where I is the identity matrix, and Λ is the eigenvalue. Notice that (µ + Λ) can be
factored out from the first row of (J−ΛI) by the row addition R1 + R2 + R3 + R4 → R1,
giving one negative eigenvalue Λ1 = −µ. The characteristic equation simplifies to
(µ+ Λ)(Λ3 + a2Λ
2 + a1Λ + a0) = 0 , (B.2)
where
a2 = βI
∗(1 + ν) + 2(2κ+ µ) ,
a1 = βI
∗[2(2κ+ µ) + γ + βνI∗ + µν] + (2κ+ µ)2 ,
a0 = βI
∗[(2κ+ µ)2 + µβνI∗ + γ(4κ+ µ+ βνI∗) + 2κβνW ∗] .
The equilibrium is locally asymptotically stable if the Routh–Hurwitz criteria are satis-
fied, and unstable otherwise.
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Appendix C. Coexisting attractors
This section provides an example of bi-stability in the two-pathogen model (Figure
C.8) with ν = 1, σ1 = σ2 = σ = 0.9805, and initial population size
X = (XSS , XIS , XRS , XWS , XSI , XII , XRI , XWI ,
XSR , XIR , XRR , XWR , XSW , XIW , XRW , XWW ) .
Initial conditions used to generate periodic solutions are
Xperiodic = (0.0571, 0.0019, 0.4443, 0.0944, 0.0014, 0.0000, 0.0002, 0.0000,
0.2163, 0.0001, 0.0367, 0.0079, 0.1156, 0.0001, 0.0198, 0.0043).
Initial conditions for a point attractor are
Xpoint = (0.0568, 0.0015, 0.3329, 0.0996, 0.0015, 0.0000, 0.0002, 0.0001,
0.3329, 0.0002, 0.0441, 0.0133, 0.0996, 0.0001, 0.0133, 0.0040)
Years
50 60 70 80 90 100
X I
S
0
0.001
0.002
0.003
σ
0.98 0.9810
0.002
0.004
Figure C.8: (Colour online) Periodic solutions (solid) with initial conditionsXperiodic, and point attractor
(dashed) solutions with initial conditions Xpoint. The red line in the bifurcation diagram (inset) shows
the value of σ = 0.9805 at ν = 1.
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